umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis
Umeå University, Faculty of Medicine, Department of Pharmacology and Clinical Neuroscience, Clinical Neuroscience.
2018 (English)Independent thesis Basic level (professional degree), 20 credits / 30 HE creditsStudent thesis
Place, publisher, year, edition, pages
2018.
National Category
Neurology
Identifiers
URN: urn:nbn:se:umu:diva-150930OAI: oai:DiVA.org:umu-150930DiVA, id: diva2:1240099
External cooperation
Västerbottens läns landsting; Stockholms läns landsting; Västra Götalandregionen
Educational program
Medical Programme
Supervisors
Examiners
Available from: 2018-08-30 Created: 2018-08-20 Last updated: 2018-08-30Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
Clinical Neuroscience
Neurology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 39 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf